Evidence map›Paper›PMID 26371510›Full record

ArticleeLife2015

Layer 2/3 pyramidal cells in the medial prefrontal cortex moderate stress induced depressive behaviors.

Prerana Shrestha, Awni Mousa, Nathaniel Heintz

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Molecular Characterization of the Progressive Landscape of Depression.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Prerana ShresthaLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.
Awni MousaLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.
Nathaniel HeintzLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.
Rockefeller University · USHoward Hughes Medical Institute · US

Funding

RESEARCH SUPPORT CORE 4P30DA035756 · NIDA · ROCKEFELLER UNIVERSITY · PI HEINTZ, NATHANIEL · 2013 to 2017
$6.7M
Howard Hughes Medical InstituteNIDA NIH HHS 5P30DA035756NIDA NIH HHS P30 DA035756NIMH NIH HHS 5P50MH090063 P2
6 · The paper itself

Abstract

Major depressive disorder (MDD) is a prevalent illness that can be precipitated by acute or chronic stress. Studies of patients with Wolfram syndrome and carriers have identified Wfs1 mutations as causative for MDD. The medial prefrontal cortex (mPFC) is known to be involved in depression and behavioral resilience, although the cell types and circuits in the mPFC that moderate depressive behaviors in response to stress have not been determined. Here, we report that deletion of Wfs1 from layer 2/3 pyramidal cells impairs the ability of the mPFC to suppress stress-induced depressive behaviors, and results in hyperactivation of the hypothalamic-pituitary-adrenal axis and altered accumulation of important growth and neurotrophic factors. Our data identify superficial layer 2/3 pyramidal cells as critical for moderation of stress in the context of depressive behaviors and suggest that dysfunction in these cells may contribute to the clinical relationship between stress and depression.

Indexed as

DepressionAnimalsFemaleGene Knockout TechniquesMaleMembrane ProteinsMiceMice, KnockoutPrefrontal CortexPyramidal CellsStress, PsychologicalMembrane Proteinswolframin proteinanxietydepressionlayer 2/3medial prefrontal cortexmouseneurosciencestresswolfram syndrome

Identifiers

PMID26371510
PMCPMC4566133
OpenAlexW2179342913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.